|
KIAA0355 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.63669974742697E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.59210430897383E-11 |
| Normal-vs-Stage2 |
6.05959999955274E-07 |
| Normal-vs-Stage3 |
2.956900E-03 |
| Normal-vs-Stage4 |
1.194360E-02 |
| Stage1-vs-Stage2 |
7.190400E-01 |
| Stage1-vs-Stage3 |
1.280980E-01 |
| Stage1-vs-Stage4 |
9.066000E-01 |
| Stage2-vs-Stage3 |
3.831400E-01 |
| Stage2-vs-Stage4 |
8.944200E-01 |
| Stage3-vs-Stage4 |
5.077200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.17999959698057E-10 |
| Normal-vs-AfricanAmerican |
3.11840000488672E-08 |
| Normal-vs-Asian |
1.815990E-03 |
| Caucasian-vs-AfricanAmerican |
9.660400E-01 |
| Caucasian-vs-Asian |
8.785600E-01 |
| AfricanAmerican-vs-Asian |
8.861600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.29110064253746E-11 |
| Normal-vs-Female |
7.67930000000749E-05 |
| Male-vs-Female |
1.690310E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.3513999615239E-09 |
| Normal-vs-Extreme_Weight |
1.2695999807022E-10 |
| Normal-vs-Obese |
4.8992000000192E-06 |
| Normal-vs-Extreme_Obese |
7.68930000005774E-07 |
| Normal_Weight-vs-Extreme_Weight |
9.150600E-01 |
| Normal_Weight-vs-Obese |
9.462300E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.280400E-01 |
| Extreme_Weight-vs-Obese |
7.095500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.843000E-01 |
| Obese-vs-Extreme_Obese |
8.166000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.199500E-02 |
| Normal-vs-Age(41-60Yrs) |
2.330999999689E-07 |
| Normal-vs-Age(61-80Yrs) |
7.23265891622304E-12 |
| Normal-vs-Age(81-100Yrs) |
1.51960000138729E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.137200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.145700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.479200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.900500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.235980E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.298000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.31750002205922E-10 |
| Normal-VS-Type2 PRCC |
7.60114193809613E-12 |
| Normal-VS-KIRP CIMP |
2.400600E-01 |
| Normal-VS-Unclassified PRCC |
6.096300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.635850E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.497980E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.183400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.183650E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.333780E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.898400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.70269995272798E-09 |
| Normal-vs-N1 |
1.920250E-02 |
| Normal-vs-N2 |
6.039800E-03 |
| N0-vs-N1 |
8.240300E-02 |
| N0-vs-N2 |
8.044000E-01 |
| N1-vs-N2 |
6.081800E-01 |
|
|
